Trump's 100% pharma tariffs will have a limited effect on the…
This new tariff appears driven by geopolitical considerations, limiting the economic impact
Watch: European pharma's fight to stay relevant
Europe's pharmaceutical industry is being squeezed by China and the US
European pharma's fight to stay relevant
Europe's pharmaceutical industry needs to up its game if it's going to continue competing effectively with the likes of China and the US. So says…
The impact of weight-loss drugs on food demand is still limited in Europe. The need for food companies to adapt will increase as the use of GLP-1s grows
Europe's pharma industry can be a powerhouse again, but it needs to act fast
Pharma’s Godfather moment: pulled back into tariff uncertainty
Dutch healthcare sector set to expand further despite supply…
Listen: Pharma 2026 - higher prices, manufacturing migration,…
Makary's successor faces tough task managing FDA amid budget cuts
Pharma’s 2026 hit list: The White Album
Pharma's 2026 hit list: The White Album
Money (That's What I Want): 2026 is the year of truth for…
Hello, Goodbye: Europe loses ground as China becomes powerhouse of…
Come Together: Pharma M&A set to accelerate in 2026
2026 should be a good year for pharma M&A as a result of reduced uncertainty and the looming patent cliff
Webinar: the pharmaceutical industry's global reset
Is the global pharmaceutical industry entering a new era?
Economic risks mount in Switzerland on tariff turbulence
Why the Pfizer-Trump pharma deal is a win for branded pharma, but not…
All over the world our analysts write about their dedicated region.
Dutch healthcare sector tackles self-employed shortage by boosting…
Listen: Pharma's bitter dose of tariff pressure
Four calls for Trump's pharmaceutical tariffs
Watch: Why there's so much concern about Trump's proposed…
